Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 37.43M | $130.0M | 12.51% | -769 | 2026-06-30 |
| Flagship Pioneering, LLC | 25.00M | $87.0M | 8.35% | -- | 2026-06-30 |
| RA CAPITAL MANAGEMENT, L.P. | 18.75M | $65.0M | 6.26% | -- | 2026-06-30 |
| BlackRock, Inc. | 16.68M | $58.0M | 5.57% | +2.43M | 2026-06-30 |
| STATE STREET CORP | 11.20M | $39.0M | 3.74% | +665.0K | 2026-06-30 |
| CANADA PENSION PLAN INVESTMENT BOARD | 10.22M | $35.0M | 3.41% | -3.5K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.38M | $29.0M | 2.80% | +940.7K | 2026-06-30 |
| BANK OF AMERICA CORP /DE/ | 5.75M | $20.0M | 1.92% | +2.80M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.68M | $16.0M | 1.56% | +496.0K | 2026-06-30 |
| Marex Group Ltd | 3.99M | $13.0M | 1.33% | -10.0K | 2026-06-30 |
